ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1417

Common Causes of Hospitalization in Spondyloarthritis Patients: A Nationwide Analysis

Faria Sami1, Maria I. ("Maio") Danila2, Liron Caplan3 and Rouhin Sen4, 1The University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham (UAB), Birmingham VA Medical Center, Birmingham, AL, 3Medicine Service, Rocky Mountain Regional VAMC, Aurora, CO, 4University of Alabama at Birmingham, Department of Medicine, Division of Clinical Immunology & Rheumatology, Birmingham

Meeting: ACR Convergence 2025

Keywords: Spondyloarthropathies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1405–1433) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Axial spondylarthritis (AxSpA), psoriatic arthritis (PsA), and inflammatory bowel disease-associated arthritis (IBD-A) are chronic inflammatory conditions with systemic involvement, leading to substantial morbidity and healthcare utilization. There is a paucity of national-level data on reasons for hospitalizations in patients with these conditions. We aimed to identify major diagnostic categories for hospitalizations and top reasons for hospitalization among patients with AxSpA, PsA, and IBD-A, using a large United States population-based database.

Methods: We conducted a retrospective cohort study using the National Inpatient Sample (NIS) from 2016 to 2020. The NIS is the largest inpatient hospitalization database in the U.S., representing 20% of hospitalizations from all non-federal acute care hospitals. We identified patients with a primary or secondary diagnosis of AxSpA, PsA, or IBD-A using ICD-10 codes. Principal diagnoses for hospitalization were analyzed and categorized into major diagnostic categories. Weighted analyses were performed to calculate national estimates of hospitalization reasons and determine the top principal diagnoses for each disease group.

Results: A total of 139,130 AxSpA, 223,745 PsA, and 1,880 IBD-A hospitalizations were analyzed. Demographics for the study cohort appear in Table 1. The top five most frequent major diagnostic categories for each group are summarized below [Table 2]:AxSpA: 1) Rheumatological disorder, 2) Injury/Poisoning, 3) Gastrointestinal disorders, 4) Cardiovascular disease, 5) Infections.PsA: 1) Cardiovascular disease, 2) Rheumatological, 3) Gastrointestinal disorders, 4) Infections, 5) Injury/Poisoning.IBD-A: 1) Gastrointestinal disorders, 2) Rheumatological disorder, 3) Infection, 4) Respiratory conditions, 5) Injury/Poisoning.The leading principal diagnoses [Table 3] for AxSpA included sacroiliitis (7.6%), sepsis (5.3%), and acute renal injury (1.3%). For PsA, the top principal diagnoses included sepsis (6.5 %), primary osteoarthritis of the knee (3.5%), and non-ST-elevated myocardial injury (1.7 %). IBD-A population was most frequently admitted for ulcerative colitis (12.2%), followed by sepsis (10.6%), and then Crohn’s disease with and without complications (6.0%)

Conclusion: Hospitalization patterns in AxSpA, PsA, and IBD-A differ by disease type but share common themes of rheumatological, cardiovascular disease, infectious, injury/poisoning, and gastrointestinal involvement. These findings may highlight key areas for targeted management and preventive efforts to optimize healthcare resource utilization and improve quality care for patients

Supporting image 1Table 1: Demographic Characteristics of Hospitalized Patients with AxSpA, PsA and IBD- A arthritis

Supporting image 2Table 2: Distribution of Principal Diagnosis Categories Among Hospitalized Patients with AxSpA, PsA, and IBD-A Arthritis Hospitalization in NIS 2016-2020.

Supporting image 3Table 3: Most Common Principal Diagnoses among Spondylarthritis Hospitalizations in NIS 2016-2020


Disclosures: F. Sami: None; M. Danila: Boehringer-Ingelheim, 2, Pfizer, 5; L. Caplan: None; R. Sen: None.

To cite this abstract in AMA style:

Sami F, Danila M, Caplan L, Sen R. Common Causes of Hospitalization in Spondyloarthritis Patients: A Nationwide Analysis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/common-causes-of-hospitalization-in-spondyloarthritis-patients-a-nationwide-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/common-causes-of-hospitalization-in-spondyloarthritis-patients-a-nationwide-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology